Atrion Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Atrion.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

May 22

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Mar 24

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Mar 23

There Are Reasons To Feel Uneasy About Atrion's (NASDAQ:ATRI) Returns On Capital

Jul 09

Here's Why Atrion Corporation's (NASDAQ:ATRI) CEO Compensation Is The Least Of Shareholders Concerns

May 15

Atrion reports Q1 results

May 10

Atrion Corporation (NASDAQ:ATRI) Is Yielding 1.1% - But Is It A Buy?

Apr 12

Atrion Corporation (NASDAQ:ATRI) Pays A US$1.75 Dividend In Just Four Days

Mar 07

Need To Know: Atrion Corporation (NASDAQ:ATRI) Insiders Have Been Buying Shares

Feb 26

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Atrion no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:ATRI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	177	19	9	27	N/A
12/31/2023	169	19	-2	20	N/A
9/30/2023	169	21	-19	9	N/A
6/30/2023	171	27	-21	14	N/A
3/31/2023	176	30	-12	21	N/A
12/31/2022	184	35	-5	29	N/A
9/30/2022	181	35	9	39	N/A
6/30/2022	179	34	17	41	N/A
3/31/2022	173	34	23	43	N/A
12/31/2021	165	33	23	39	N/A
9/30/2021	157	32	21	39	N/A
6/30/2021	148	31	15	36	N/A
3/31/2021	143	31	12	34	N/A
12/31/2020	148	32	17	39	N/A
9/30/2020	150	33	15	35	N/A
6/30/2020	155	35	18	38	N/A
3/31/2020	157	36	22	42	N/A
12/31/2019	155	37	22	42	N/A
9/30/2019	156	36	27	47	N/A
6/30/2019	156	36	27	46	N/A
3/31/2019	155	35	28	46	N/A
12/31/2018	152	34	26	43	N/A
9/30/2018	152	35	28	43	N/A
6/30/2018	150	34	36	48	N/A
3/31/2018	147	35	37	47	N/A
12/31/2017	147	37	N/A	47	N/A
9/30/2017	146	34	N/A	46	N/A
6/30/2017	146	33	N/A	43	N/A
3/31/2017	146	31	N/A	40	N/A
12/31/2016	143	28	N/A	37	N/A
9/30/2016	143	28	N/A	38	N/A
6/30/2016	142	28	N/A	38	N/A
3/31/2016	144	28	N/A	40	N/A
12/31/2015	146	29	N/A	40	N/A
9/30/2015	146	29	N/A	38	N/A
6/30/2015	145	29	N/A	34	N/A
3/31/2015	143	28	N/A	32	N/A
12/31/2014	141	28	N/A	31	N/A
9/30/2014	140	28	N/A	32	N/A
6/30/2014	137	28	N/A	35	N/A
3/31/2014	135	27	N/A	36	N/A
12/31/2013	132	27	N/A	37	N/A
9/30/2013	129	26	N/A	33	N/A
6/30/2013	125	25	N/A	35	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de ATRI es superior a la tasa de ahorro (2.4%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de ATRI crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de ATRI crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de ATRI crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de ATRI crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de ATRI se prevé que sea elevada dentro de 3 años.

Atrion Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Atrion Corporation Provides Production Guidance for the Third Quarter of 2024

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Recent updates

Upcoming dividend of US$2.20 per share

Nordson Medical Corporation entered into an agreement to acquire Atrion Corporation (NasdaqGS:ATRI) for approximately $820 million.

First quarter dividend of US$2.20 announced

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 28, 2024

First quarter 2024 earnings released: EPS: US$1.59 (vs US$1.98 in 1Q 2023)

Atrion Corporation Provides Production Guidance for the Third Quarter of 2024

Atrion Corporation, Annual General Meeting, May 21, 2024

Investor sentiment improves as stock rises 16%

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Investor sentiment improves as stock rises 23%

Upcoming dividend of US$2.20 per share

Fourth quarter dividend of US$2.20 announced

Investor sentiment improves as stock rises 17%

Here's Why Atrion (NASDAQ:ATRI) Can Manage Its Debt Responsibly

Atrion Corporation's (NASDAQ:ATRI) 26% Share Price Surge Not Quite Adding Up

Investor sentiment improves as stock rises 16%

Independent Director recently bought US$96k worth of stock

Upcoming dividend of US$2.20 per share at 3.0% yield

President & CEO recently bought US$90k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023

New minor risk - Profit margin trend

Third quarter 2023 earnings released: EPS: US$1.67 (vs US$4.95 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Atrion Corporation Announces Election of Jeannette Bankes as Director

Atrion (NASDAQ:ATRI) Seems To Use Debt Quite Sensibly

Upcoming dividend of US$2.20 per share at 1.9% yield

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$3.73 (vs US$5.21 in 2Q 2022)

Atrion (NASDAQ:ATRI) Will Want To Turn Around Its Return Trends

Executive Chairman exercised options and sold US$176k worth of stock

Upcoming dividend of US$2.15 per share at 1.6% yield

Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023

First quarter 2023 earnings released: EPS: US$1.98 (vs US$4.72 in 1Q 2022)

Be Wary Of Atrion (NASDAQ:ATRI) And Its Returns On Capital

Upcoming dividend of US$2.15 per share at 1.4% yield

Full year 2022 earnings released: EPS: US$19.59 (vs US$18.22 in FY 2021)

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of US$2.15 per share

Insufficient new directors

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2022

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Third quarter 2022 earnings released: EPS: US$4.95 (vs US$4.59 in 3Q 2021)

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Insufficient new directors

Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital

Atrion Corporation Announces Resignation of Maria Sainz from the Board of Directors, Effective from October 21, 2022

Atrion: Attractively Priced For Exposure To Defensive Healthcare

Upcoming dividend of US$2.15 per share

CFO, VP exercised options and sold US$51k worth of stock

Atrion's (NASDAQ:ATRI) Upcoming Dividend Will Be Larger Than Last Year's

Atrion Corporation Announces CFO Changes

Atrion Corporation Increases Quarterly Cash Dividend, Payable on September 30, 2022

Atrion raises dividend 10.3% to $2.15/share

Second quarter 2022 earnings released: EPS: US$5.21 (vs US$4.89 in 2Q 2021)

Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital

Executive Chairman exercised options and sold US$582k worth of stock

Atrion Corporation Announces Jeffery Strickland Intends to Retire as Secretary and Treasurer Effective March 3, 2023

Upcoming dividend of US$1.95 per share

CFO, VP exercised options and sold US$79k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

First quarter 2022 earnings released: EPS: US$4.72 (vs US$4.23 in 1Q 2021)

Atrion Corporation, Annual General Meeting, May 24, 2022

Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$1.95 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Atrion Corporation Declares Quarterly Cash Dividend, Payable on March 31, 2022

Atrion (NASDAQ:ATRI) Could Be Struggling To Allocate Capital

Executive Chairman recently sold US$137k worth of stock